P3 Health Partners (PIII) Stock Statistics & Valuation Metrics

P3 Health Partners has a market cap or net worth of $48.80M. The enterprise value is $59.76M.

P3 Health Partners has 3,268,093 shares outstanding. The number of shares has decreased by -2.65% in one year.

P3 Health Partners’s return on equity (ROE) is -1.79 and return on invested capital (ROIC) is -90.08%.

The current PE Ratio of P3 Health Partners is -0.24. P3 Health Partners’s PEG ratio is ―.

In the last 12 months, P3 Health Partners had revenue of 1.50B and earned -135.85M in profits. Earnings per share was -0.94.

In the last 12 months, operating cash flow was -123.56M and capital expenditures 0.00, giving a free cash flow of -123.56M billion.

P3 Health Partners pays an annual dividend of ―, resulting in a dividend yield of ―

P3 Health Partners upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.

P3 Health Partners as a current ratio of 0.37, with Debt / Equity ratio of 120.13%

In the past 12 months, P3 Health Partners has paid 4.39M in taxes.

P3 Health Partners EV to EBITDA ratio is -0.81, with an EV/FCF ratio of -1.45.

P3 Health Partners has $40.08M in cash and marketable securities with $75.98M in debt, giving a net cash position of $35.90M billion.

Gross margin is -1.48%, with operating margin of -20.83%, and net profit margin of -9.05%.

The average price target for P3 Health Partners is $14.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy